AAAAAA
Results:
1-21
|
Results: 21
Authors:
Flynn, K
Rimm, DL
Citation: K. Flynn et Dl. Rimm, Diagnosis of "ASCUS" in women over age 50 is less likely to be associated with dysplasia, DIAGN CYTOP, 24(2), 2001, pp. 132-136
Authors:
Rimm, DL
Camp, RL
Charette, LA
Costa, J
Olsen, DA
Reiss, M
Citation: Dl. Rimm et al., Tissue microarray: A new technology for amplification of tissue resources, CANCER J, 7(1), 2001, pp. 24-31
Authors:
Reyes-Mugica, M
Meyerhardt, JA
Rzasa, J
Rimm, DL
Johnson, KR
Wheelock, MJ
Reale, MA
Citation: M. Reyes-mugica et al., Truncated DCC reduces N-cadherin/catenin expression and calcium-dependent cell adhesion in neuroblastoma cells, LAB INV, 81(2), 2001, pp. 201-210
Authors:
Pradhan, D
Lombardo, CR
Roe, S
Rimm, DL
Morrow, JS
Citation: D. Pradhan et al., alpha-Catenin binds directly to spectrin and facilitates spectrin-membraneassembly in vivo, J BIOL CHEM, 276(6), 2001, pp. 4175-4181
Authors:
Chen, TP
Yan, W
Wells, RG
Rimm, DL
McNiff, J
Leffell, D
Reiss, M
Citation: Tp. Chen et al., Novel inactivating mutations of transforming growth factor-beta type I receptor gene in head-and-neck cancer metastases, INT J CANC, 93(5), 2001, pp. 653-661
Authors:
Garcia-Rostan, G
Camp, RL
Herrero, A
Carcangiu, ML
Rimm, DL
Tallini, G
Citation: G. Garcia-rostan et al., beta-Catenin dysregulation in thyroid neoplasms - Down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis, AM J PATH, 158(3), 2001, pp. 987-996
Authors:
Rimm, DL
Citation: Dl. Rimm, Impact of microarray technologies on cytopathology - Overview of technologies and commentary on current and future implications for pathologists and cytopathologists, ACT CYTOL, 45(2), 2001, pp. 111-114
Authors:
Schofield, K
D'Aquila, T
Rimm, DL
Citation: K. Schofield et al., E-cadherin expression is a sensitive and specific method for detection of carcinoma cells in fluid specimens, DIAGN CYTOP, 22(5), 2000, pp. 263-267
Authors:
Dillon, DA
Johnson, CC
Topazian, MD
Tallini, G
Rimm, DL
Costa, JC
Citation: Da. Dillon et al., The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasms, CANCER J, 6(5), 2000, pp. 294-301
Authors:
Camp, RL
Charette, LA
Rimm, DL
Citation: Rl. Camp et al., Validation of tissue microarray technology in breast carcinoma, LAB INV, 80(12), 2000, pp. 1943-1949
Authors:
Rimm, DL
Citation: Dl. Rimm, Molecular biology in cytopathology - Current applications and future directions, CANC CYTOP, 90(1), 2000, pp. 1-9
Authors:
Camp, RL
Rimm, EB
Rimm, DL
Citation: Rl. Camp et al., A high number of tumor free axillary lymph nodes from patients with lymph node negative breast is associated with poor outcome - Author reply, CANCER, 89(1), 2000, pp. 218-219
Authors:
Camp, RL
Rimm, EB
Rimm, DL
Citation: Rl. Camp et al., A high number of tumor free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome, CANCER, 88(1), 2000, pp. 108-113
Authors:
Rimm, DL
Sherman, ME
Citation: Dl. Rimm et Me. Sherman, The new molecular biology section of acta cytologica - An introduction, ACT CYTOL, 44(5), 2000, pp. 701-702
Authors:
Caca, K
Kolligs, FT
Ji, XD
Hayes, M
Qian, JM
Yahanda, A
Rimm, DL
Costa, J
Fearon, ER
Citation: K. Caca et al., beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer, CELL GROWTH, 10(6), 1999, pp. 369-376
Authors:
Provost, E
Rimm, DL
Citation: E. Provost et Dl. Rimm, Controversies at the cytoplasmic face of the cadherin-based adhesion complex, CURR OP CEL, 11(5), 1999, pp. 567-572
Authors:
Ilan, N
Mahooti, S
Rimm, DL
Madri, JA
Citation: N. Ilan et al., PECAM-1 (CD31) functions as a reservoir for and a modulator of tyrosine-phosphorylated beta-catenin, J CELL SCI, 112(18), 1999, pp. 3005-3014
Authors:
Garcia-Rostan, G
Tallini, G
Herrero, A
D'Aquila, TG
Carcangiu, ML
Rimm, DL
Citation: G. Garcia-rostan et al., Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma, CANCER RES, 59(8), 1999, pp. 1811-1815
Authors:
Camp, RL
Rimm, EB
Rimm, DL
Citation: Rl. Camp et al., Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma, CANCER, 86(11), 1999, pp. 2259-2265
Authors:
Rimm, DL
Caca, K
Hu, G
Harrison, FB
Fearon, ER
Citation: Dl. Rimm et al., Frequent Nuclear/Cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma, AM J PATH, 154(2), 1999, pp. 325-329
Authors:
Gold, JS
Reynolds, AB
Rimm, DL
Citation: Js. Gold et al., Loss of p120ctn in human colorectal cancer predicts metastasis and poor survival, CANCER LETT, 132(1-2), 1998, pp. 193-201
Risultati:
1-21
|